Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01122238Phase 4Completed

Identifying Treatments to Motivate Smokers to Quit

Role: collaborator

NCT01120704Phase 4Completed

Evaluation of Treatments to Improve Smoking Cessation Medication Adherence

Role: collaborator

NCT01116986Phase 4Completed

Identifying Optimal Smoking Cessation Intervention Components (Cessation)

Role: collaborator

NCT00478764Not ApplicableCompleted

Intraocular Steroid After Cataract Surgery Study

Role: lead

All 4 trials loaded